AlphaQuest’s Krystal Biotech KRYS Stock Holding History

AlphaQuest’s Portfolio KRYS Stock Details KRYS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-565	Closed	-$139K	–	1084
2025 Q4	$139K	Sell	565 -99	-15%	-$20.8K	0.01%	1603
2025 Q3	$117K	Buy	664 +85	+15%	+$12.7K	0.01%	1655
2025 Q2	$79.6K	Sell	579 -1,084	-65%	-$159K	0.01%	1499
2025 Q1	$300K	Sell	1,663 -1,357	-45%	-$228K	0.03%	773
2024 Q4	$473K	Buy	3,020 +1,622	+116%	+$288K	0.06%	508
2024 Q3	$254K	Buy	1,398 +1,014	+264%	+$196K	0.02%	966
2024 Q2	$70.5K	Buy	+384	New	+$64.5K	0.01%	1017
2024 Q1	–	Sell	-1,022	Closed	-$127K	–	1725
2023 Q4	$127K	Buy	+1,022	New	+$113K	0.03%	717

Other funds holding KRYS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AlphaQuest's KRYS Position: Q1 2026 in Review

AlphaQuest sold out of Krystal Biotech (KRYS) in Q1 2026, closing a stake of 565 shares — an estimated $139K sold.

AlphaQuest first reported a position in KRYS in Q4 2023 and held it in 8 quarters. The position peaked at $473K in Q4 2024. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

AlphaQuest reported no remaining Krystal Biotech position as of Q1 2026 after selling out during the quarter.
AlphaQuest sold 565 Krystal Biotech shares in Q1 2026, an estimated $139K.
AlphaQuest first reported a position in Krystal Biotech in Q4 2023 and held it in 8 quarters.
AlphaQuest's Krystal Biotech position peaked at $473K in Q4 2024.
367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.